Home > M&A deals 2006 > Sangamo BioSciences, Inc. acquires Edwards Lifesciences Corp. - Angiogenesis Program
Divestiture · Life Science · April 2006

Sangamo BioSciences, Inc. acquires Edwards Lifesciences Corp. - Angiogenesis Program

On April 12, 2006, Sangamo BioSciences, Inc. acquired Edwards Lifesciences Corp. - Angiogenesis Program, a life science company in California, United States.

Deal at a glance

AnnouncedApril 12, 2006 TypeDivestiture TargetEdwards Lifesciences Corp. - Angiogenesis Program Buyer Sangamo BioSciences, Inc. SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

Edwards Lifesciences Corp. - Angiogenesis Program
California, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Sangamo BioSciences, Inc.
Company · 5 deals on record
  • 2nd transaction in life science
  • 1st transaction in United States
5deals, all time
4in this sector
2018latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Edwards Lifesciences Corp. - Angiogenesis Program?Sangamo BioSciences, Inc. acquired Edwards Lifesciences Corp. - Angiogenesis Program on April 12, 2006.

What type of deal was it?It was a divestiture in the life science sector in 2006.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).